BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 37334292)

  • 1. COVID-19 vaccine coverage, safety, and perceptions among patients with diabetes mellitus in China: a cross-sectional study.
    Li H; Ping F; Li X; Wang Z; Xiao J; Jiang H; Xue Y; Quan J; Yao H; Zheng X; Chen Y; Li Y; Yu X; Xu L; Feng X; Wang S; Li Y; Xiao X
    Front Endocrinol (Lausanne); 2023; 14():1172089. PubMed ID: 37334292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
    Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
    Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of COVID-19 Vaccine Acceptance and Hesitancy: A Health Care Student-Based Online Survey in Northwest China.
    Zhang J; Dean J; Yin Y; Wang D; Sun Y; Zhao Z; Wang J
    Front Public Health; 2021; 9():777565. PubMed ID: 35071162
    [No Abstract]   [Full Text] [Related]  

  • 4. Safety of third SARS-CoV-2 vaccine (booster dose) during pregnancy.
    Dick A; Rosenbloom JI; Karavani G; Gutman-Ido E; Lessans N; Chill HH
    Am J Obstet Gynecol MFM; 2022 Jul; 4(4):100637. PubMed ID: 35398583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Actual Status of Hospitals as COVID-19 Vaccination Clinics in China and Safety Monitoring of Inactivated Vaccine: A Cross-Sectional Study.
    Huang J; Zhang MQ; Huang MZ; Lin GM
    Disaster Med Public Health Prep; 2022 Aug; 17():e256. PubMed ID: 36017705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study.
    Menni C; May A; Polidori L; Louca P; Wolf J; Capdevila J; Hu C; Ourselin S; Steves CJ; Valdes AM; Spector TD
    Lancet Infect Dis; 2022 Jul; 22(7):1002-1010. PubMed ID: 35405090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 vaccination coverage in Egypt: a large-scale national survey - to help achieving vaccination target, March-May, 2022.
    Kandeel A; Eldeyahy I; Abu ElSood H; Fahim M; Afifi S; Abu Kamar S; BahaaEldin H; Ahmed E; Mohsen A; Abdelghaffar K
    BMC Public Health; 2023 Feb; 23(1):397. PubMed ID: 36849954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acceptance of the COVID-19 vaccine booster dose and associated factors among the elderly in China based on the health belief model (HBM): A national cross-sectional study.
    Qin C; Yan W; Du M; Liu Q; Tao L; Liu M; Liu J
    Front Public Health; 2022; 10():986916. PubMed ID: 36589991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of COVID-19 Vaccination in Patients With Breast Cancer: Cross-Sectional Study in China.
    Zhang S; Li J; Xu R; Chen Q; Sun G; Lin Y; Cao Y; Chen Y; Geng C; Teng Y; Nie J; Li X; Xu G; Liu X; Jin F; Fan Z; Luo T; Liu H; Wang FS; Jiang Z
    JMIR Public Health Surveill; 2023 Dec; 9():e46009. PubMed ID: 38060302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 vaccination coverage among adolescents aged 12-17 years in three provinces of eastern China: A cross-sectional survey, 2021.
    Li T; Qi R; Chen B; Luo Y; Zhang W; Zhou YH; Xu B
    Front Public Health; 2022; 10():919190. PubMed ID: 35937249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 vaccination during pregnancy: coverage and safety.
    Blakeway H; Prasad S; Kalafat E; Heath PT; Ladhani SN; Le Doare K; Magee LA; O'Brien P; Rezvani A; von Dadelszen P; Khalil A
    Am J Obstet Gynecol; 2022 Feb; 226(2):236.e1-236.e14. PubMed ID: 34389291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coverage and predictors of COVID-19 vaccination in rural districts of Pakistan.
    Shaikh S; Maheshwari G; Nawaz Samoo A; Mustafa Soomro G; Mazharullah L
    East Mediterr Health J; 2024 May; 30(4):264-271. PubMed ID: 38808402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China.
    Zhang XR; Li ZJ; Fu Q; Wang JD; Huang QM; Song WQ; Xu XY; Li ZH; Mao C
    BMC Public Health; 2023 Mar; 23(1):542. PubMed ID: 36949421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-dimensional potential factors influencing COVID-19 vaccine booster acceptance and hesitancy among university academic community in Bangladesh: A cross-sectional comparative study.
    Roy DN; Azam MS; Islam E
    PLoS One; 2023; 18(4):e0281395. PubMed ID: 37053270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low uptake of COVID-19 booster doses among elderly cancer patients in China: A multicentre cross-sectional study.
    Chai R; Yang J; Su R; Lan X; Song M; Zhang L; Xu J
    J Glob Health; 2024 Feb; 14():05010. PubMed ID: 38303680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Safety Analysis of the ChAdOx1-nCoV-19 Corona Virus Vaccine: Results from a Prospective Observational Study in Priority Vaccinated Groups in North India.
    Kaur U; Fatima Z; Maheshwari K; Sahni V; Dehade A; Kl A; Yadav AK; Kansal S; Jaisawal V; Chakrabarti SS
    Drug Saf; 2023 Jun; 46(6):553-563. PubMed ID: 37133805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination coverage among COVID-19 prevention and control management teams at primary healthcare facilities in China and their attitudes towards COVID-19 vaccine: a cross-sectional online survey.
    Yan YY; Wang HT; Fan TY; Sun XJ; Du ZH; Sun XM
    BMJ Open; 2022 Apr; 12(4):e056345. PubMed ID: 35393315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers.
    Angel Y; Spitzer A; Henig O; Saiag E; Sprecher E; Padova H; Ben-Ami R
    JAMA; 2021 Jun; 325(24):2457-2465. PubMed ID: 33956048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of COVID-19 vaccines in pregnancy: a Canadian National Vaccine Safety (CANVAS) network cohort study.
    Sadarangani M; Soe P; Shulha HP; Valiquette L; Vanderkooi OG; Kellner JD; Muller MP; Top KA; Isenor JE; McGeer A; Irvine M; De Serres G; Marty K; Bettinger JA;
    Lancet Infect Dis; 2022 Nov; 22(11):1553-1564. PubMed ID: 35964614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.